Ignite Creation Date:
2024-05-05 @ 9:47 PM
Last Modification Date:
2024-10-26 @ 10:09 AM
Study NCT ID:
NCT00963326
Status:
UNKNOWN
Last Update Posted:
2011-02-28
First Post:
2009-08-20
Brief Title:
Study of Blood and Tissue Samples From Patients With Larynx Cancer Pharynx Cancer or Oral Cavity Cancer
Sponsor:
Centre Oscar Lambret
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
Morphological and Molecular Characterization of Tumors of the Aero-digestive Tract in Patients Who Have no Risk Factors Such as Alcohol Smoking or Occupation
Status:
UNKNOWN
Status Verified Date:
2011-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
PURPOSE This research study is looking at blood and tissue samples from patients with larynx cancer pharynx cancer or oral cavity cancer
PURPOSE This research study is looking at blood and tissue samples from patients with larynx cancer pharynx cancer or oral cavity cancer
Detailed Description:
OBJECTIVES
Primary
Characterize morphologically and molecularly squamous cell carcinoma of the larynx pharynx or oral cavity in patients without high-risk factors such as alcohol consumption smoking or occupation
Secondary
Study the impact parameters of morphology molecular characteristics and genomics on disease-free survival and overall survival of these patients
Study the impact parameters of morphological molecular and genomic control in the tumor
Assess in advanced tumors the risk of heterogeneity of morphological molecular and genomic control in the tumor
OUTLINE This is a multicenter study
Blood tumor tissue and healthy tissue samples are collected before treatment begins
Patients are followed up every 3 months for 2 years additional biopsies may be collected
Primary
Characterize morphologically and molecularly squamous cell carcinoma of the larynx pharynx or oral cavity in patients without high-risk factors such as alcohol consumption smoking or occupation
Secondary
Study the impact parameters of morphology molecular characteristics and genomics on disease-free survival and overall survival of these patients
Study the impact parameters of morphological molecular and genomic control in the tumor
Assess in advanced tumors the risk of heterogeneity of morphological molecular and genomic control in the tumor
OUTLINE This is a multicenter study
Blood tumor tissue and healthy tissue samples are collected before treatment begins
Patients are followed up every 3 months for 2 years additional biopsies may be collected
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ID-RCB-2008-A00300-55 | None | None | None |
| COL-CARIO | None | None | None |
| 2007-11 | None | None | None |
| INCA-RECF0897 | None | None | None |